Alkylating potential of DBCP on cellular macromolecules in vitro and in vivo was investigated using 14C-DBCP and male Wistar rats. In studies in vitro with rat-liver-microsome system, incorporation of DBCP-radiocarbon into TCA-and organic-solvents unextractable microsomal proteins was determined. The incorporation was dependent on incubation time, 14C-DBCP concentration, enzymatically active microsomes, NADPH, and oxygen, but it was not affected by sufficient puromycin to inhibit protein synthesis. Addition of SKF-525A, diethyldithiocarbamic acid, cysteine, or glutathione prevented the incorporation, and low concentration of 1, 1, 1-trichloropropane-2, 3-oxide, an inhibitor of epoxide hydrase stimulated the incorporation. When 14C-DBCP (20 mg/ kg) was orally administered to rats, TCA-and organic-solvents unextractable macromolecular residues were formed in rat tissues in parallel to the depletion of hepatic glutathione. Gel-fitration, protease digestion, and 2, 4-dinitrofluorobenzene treating of the liver homogenate showed an existence of radioactive proteins of which primary structure was radiolabeled. DNA isolated from the liver was also radiolabeled. From these results it was concluded that DBCP is oxidatively metabolized to reactive metabolic intermediate(s) by microsomal cytochrome p-450 system and covalently bind with nucleophilic sites of the cellular macromolecules in vitro and also in vivo. And epoxide was proposed as one of the reactive metabolic intermediate(s) responsible for protein alkylation by DBCP.